Clinical Trials on SLL

Total 431830 results

Dana-Farber Cancer Institute
GlaxoSmithKline; National Comprehensive Cancer Network

Terminated

Ofatumumab With High Dose Methylprednisone Followed by Ofatumumab and Alemtuzumab in 17p CLL

CLL | SLL

United States
Stichting Hemato-Oncologie voor Volwassenen Nederland

Recruiting

REtreatment With VEnetoclax and Acalabrutinib After Venetoclax Limited Duration (REVEAL)

CLL/SLL

Netherlands, Belgium, Denmark
Beijing InnoCare Pharma Tech Co., Ltd.

Active, not recruiting

A Study to Evaluate ICP-022 in Patients With CLL/ SLL

CLL/SLL

China
BioNova Pharmaceuticals (Shanghai) LTD.

Withdrawn

A Study of BN102 in Patients With Previously Treated CLL/SLL and B-cell NHL

NHL | CLL/SLL

China
Ascentage Pharma Group Inc.

Recruiting

A Global Study of Lisaftoclax (APG-2575) Combined With Acalabrutinib Versus Immunochemotherapy for Newly Diagnosed CLL/SLL.

CLL/SLL

China
Ascentage Pharma Group Inc.

Recruiting

Global Trial in APG2575 for Patients With CLL/SLL

CLL/SLL

Russian Federation
Shandong University

Not yet recruiting

the Real World Study of Orelabrutinib in the Treatment of CLL/SLL

CLL/SLL
Stichting Hemato-Oncologie voor Volwassenen Nederland
German CLL Study Group; Nordic CLL Study Group

Recruiting

Venetoclax Treatment (26 Cycles) With 6 Cycles or 12 Cycles of Epcoritamab in Patients With Relapsed or Refractory CLL or SLL (AETHER)

CLL/SLL

Netherlands, Denmark, Belgium, Germany
Ascentage Pharma Group Inc.

Recruiting

Study of APG-2575 as a Single Agent or in Combination With Other Therapeutic Agents for CLL/SLL

CLL/SLL

United States, Australia
Nanfang Hospital, Southern Medical University

Not yet recruiting

Clinical Study of Orelabrutinib Combined With BG Regimen First-line Treatment of CLL/SLL (CLL-OBG)

CLL/SLL

China
Peking University People's Hospital

Recruiting

A Study of Orelabrutinib in CLL/SLL Patients Who Are Slowly Responding to Ibrutinib

CLL/SLL

China
University of Pennsylvania

Completed

Dose Optimization Trial of CD19 Redirected Autologous T Cells

Adult Patients Who Have Relapsed or Refractory CLL (3rd Line) or SLL

United States
Memorial Sloan Kettering Cancer Center
Pharmacyclics LLC.

Withdrawn

A Time-Limited Approach to Treatment With Ibrutinib for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | CLL | CLL/SLL | SLL

United States
Weill Medical College of Cornell University
AstraZeneca

Withdrawn

Early Intervention With Acalabrutinib in Patients With High Risk CLL

Chronic Lymphocytic Leukemia | CLL/SLL

United States
Weill Medical College of Cornell University
TG Therapeutics, Inc.

Terminated

Umbralisib Plus Ublituximab (U2) in Progressive CLL After Novel Therapy

Chronic Lymphocytic Leukemia | CLL/SLL | CLL Progression

United States
Ångstrom Pharmaceuticals

Terminated

Safety, Tolerability and Efficacy of A6 in Patients With Chronic Lymphocytic Leukemia (CLL)

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | CLL | SLL

United States
French Innovative Leukemia Organisation
AbbVie; AstraZeneca; BeiGene; Janssen-Cilag Ltd.

Recruiting

French Observational Study of Patients With Chronic Lymphocytic Leukemia Or Small Lymphocytic Lymphoma in Real-World Settings (FOLLOW)

CLL/SLL

France
University of Wisconsin, Madison
Genentech, Inc.; Celgene Corporation

Withdrawn

Phase II Study of Bendamustine and Rituximab Induction Chemoimmunotherapy Followed by Maintenance Rituximab (Rituxan®) and Lenalidomide (Revlimid®) in Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)

Chronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL)
Niguarda Hospital

Recruiting

ObinutuzuMab AtezOlizumab and VenetocLax in RichTer transfOrmation (MOLTO)

CLL Transformation

Italy, Switzerland
Stichting Hemato-Oncologie voor Volwassenen Nederland
Nordic Lymphoma Group

Active, not recruiting

CLL Induction Treatment With Venetoclax and Ibrutinib, Followed by Ibrutinib and Obinutuzumab in Patients With MRD.

CLL

Netherlands, Denmark
Rigshospitalet, Denmark
Karolinska Institutet; Academisch Medisch Centrum - Universiteit van Amsterdam... and other collaborators

Recruiting

Acalabrutinib and Venetoclax Treatment of Newly Diagnosed Patients With CLL at High Risk of Infection or Early Treatment

CLL

Denmark, Sweden, Netherlands
National Heart, Lung, and Blood Institute (NHLBI)

Terminated

Duvelisib for Ibrutinib-Resistant Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Chronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Leukemia (SLL)

United States
Hospital Sao Domingos

Not yet recruiting

Impact of Interventions on Admissional SOFA Score on Clinical Outcomes of Critically Ill Patients

Critically Ill Patients
Fundació Institut de Recerca de l'Hospital de la...

Unknown

Effect of a Music Therapy Intervention on Mood

Critically Ill Patient

Spain
Nestlé

Completed

Improvement Project To Optimizing Nutrition With Higher Protein and Calorie Pediatric Tube Feeding

Critically Ill Children

United States
University of Zurich
Intuitive Surgical

Unknown

ICG- Livertest Versus New Biomarkers as Prognostic Markers in Critically Ill ICG- Livertest Versus New Biomarkers as Prognostic Markers in Critically Ill ((Greenpep))

Critically Ill Patients

Switzerland
Policlinico Hospital

Completed

The Estimation of Abdominal Pressure by the Bladder and Gastric Pressure

Critically Ill Patients

Italy
Niveus Medical, Inc.

Terminated

Safety and Performance of Muscle Activation for Critical Care Patients

Critically-ill

United States
Wuhan Union Hospital, China

Recruiting

Esketamine Induction Intubation in ICU Patients.

Critically Ill Patients

China
Hospital Sao Domingos

Completed

Impact of Admission SOFA Score and 48-hour Delta SOFA on Clinical Outcomes in Critically Ill Patients

Critically Ill Patients

Brazil
Universitaire Ziekenhuizen KU Leuven
KU Leuven

Completed

Therapeutic Drug Monitoring of Fluconazole in Critically Ill Patients

Critically Ill Patients

Belgium
The Hospital for Sick Children

Completed

Evaluating Processes of Care & the Outcomes of Children in Hospital (EPOCH) (EPOCH)

Critically Ill Children

United Kingdom, Canada, Ireland, Italy, New Zealand, Belgium, Netherlands
Virginia Commonwealth University
Gilead Sciences

Withdrawn

Rituximab, Idelalisib, and Venetoclax in Relapsed/Refractory CLL/SLL (RIVe-CLL/SLL)

Chronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | CLL | Refractory Small Lymphocytic Lymphoma | SLL | Relapsed CLL | Relapsed Chronic Lymphocytic Leukemia | Relapsed Small Lymphocytic Lymphoma
University Hospital Southampton NHS Foundation...

Completed

Looking at the Physiological Response of Ergometry in Critical Care Patients

Critical Ill Patients
National Heart, Lung, and Blood Institute (NHLBI)

Active, not recruiting

PCI-32765 for Special Cases of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Leukemia | CLL (Chronic Lymphocytic Leukemia) | Leukemia, Lymphocytyc | SLL (Small Lymphocytic Lymphoma)

United States
Lev-Hasharon Mental Healtlh Center

Unknown

Family Involvement in The Treatment Of a Mentally Ill Relative

Families of Mentally Ill

Israel
China Medical University Hospital

Recruiting

Traditional Chinese Medicine for Complications in Critically Ill Patients

Critically Ill Patients

Taiwan
Hospital Sao Domingos

Completed

High Protein Intake and Early Exercise in Adult Intensive Care Patients

Critically Ill Patients

Brazil
Ain Shams University

Unknown

Itopride in Feeding Intolerance of Critically-ill Patients Receiving Enteral Nutrition

Critically-ill Patients

Egypt
Hôpital Edouard Herriot

Completed

Ultrasound Assessment of Residual Gastric Content in Critically Ill Patients (GastrICU)

Critically Ill Patients

France
University of Aarhus
Central Denmark Region

Withdrawn

Videoconferencing Between Ambulances and Physician Manned Rapid Response Vehicles, Effects on On-site Patient Treatment and Patterns of Referral

All Acutely Ill or Injured Patients Receiving Care by Ambulance Personnel

Denmark
Johannes Gutenberg University Mainz

Unknown

Regional Cerebral Hemodynamics Related to Global Hemodynamics

Critically Ill Patients

Germany
Kaohsiung Veterans General Hospital.

Completed

Influence of Tightly Glucose Control on Hyperglycemic Toxicity and Protein Catabolism in Critically Ill Patients

Critically Ill Patients

Taiwan
St. Antonius Hospital

Completed

Pain Measurement and Pain Management in the Intensive Care Unit(ICU) (PIJNICU2)

Critically Ill Patients
University Hospital, Ghent

Completed

Adherence, Efficacy and Safety of an Insulin Protocol in the Critically Ill: A Prospective Observational Study

Critically Ill Patients

Belgium
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Clearance of Vasoactive Metabolites With Blood Purification (VITAL)

Critically Ill Patients

France
Australian and New Zealand Intensive Care Research...
National Health and Medical Research Council, Australia; Intensive Care National... and other collaborators

Completed

Treatment of Invasively Ventilated Adults With Early Activity and Mobilisation (TEAM(III))

Critically Ill, Mechanically Ventilated

Australia, New Zealand, United Kingdom, Ireland, Germany
Chris Hani Baragwanath Academic Hospital
Masimo Corporation

Completed

Usefulness of Non-invasive Pulse Co-oximetry Haemaglobin Measurements in Critically Ill Black Patients

Critically Ill Black Patients

South Africa
Wang Xin

Recruiting

Phase IV Observational Study of Orelabrutinib in the Treatment of Chronic Lymphocytic Leukemia/Small Cell Lymphoma

CLL/SLL

China
Genzyme, a Sanofi Company

Completed

Study of AMD3100 (Plerixafor) and Rituximab in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Chronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL)

United States

Clinical Trials on SLL

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lithuania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations